Jay Moyes
Board Member
Sintx Technologies, Inc. (SINT)Board Member
Achieve Life Sciences, Inc. (ACHV)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2017-01-01–present
-
Current
-
Current
-
Start not stated–2023-06-07
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Sera Prognostics, Inc. (SERA) | Chief Financial Officer Represents the aggregate grant date fair value of option awards granted in the applicable fiscal year. Grant date fair value is calculated in accordance with Accounting Standards Codification (“ASC”) Topic 718 (“ASC 718”) issued by the Financial Accounting Standards Board. For the assumptions relating to valuations of equity awards made to our named executive officers, see Note 11 to our audited financial statements, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the SEC on March 22, 2023. Consists of bonus payments received under our non-equity incentive compensation plans based upon satisfaction of performance goals. See “Executive Compensation — Non-Equity Incentive Compensation Plan.” Consists of matching contributions made under our 401(k) plan on behalf of each NEO. Dr. Foley’s employment commenced on December 30, 2021, and his compensation in 2021 consisted of a sign-on bonus. | $421,100 | $945,539 |
| 2021 | Sera Prognostics, Inc. (SERA) | Chief Financial Officer Represents the aggregate grant date fair value of option awards granted in the applicable fiscal year. Grant date fair value is calculated in accordance with Accounting Standards Codification (“ASC”) Topic 718 (“ASC 718”) issued by the Financial Accounting Standards Board. For the assumptions relating to valuations of equity awards made to our named executive officers, see Note 11 to our audited financial statements, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the SEC on March 22, 2023. Consists of bonus payments received under our non-equity incentive compensation plans based upon satisfaction of performance goals. See “Executive Compensation — Non-Equity Incentive Compensation Plan.” Consists of matching contributions made under our 401(k) plan on behalf of each NEO. Dr. Foley’s employment commenced on December 30, 2021, and his compensation in 2021 consisted of a sign-on bonus. | $380,100 | $945,891 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.